Advil, marketed by SKB, along with Bristol Myers's Nuprin, promptly came to market, benefiting from ibuprofen's successful ten-year track record.
Advil, promoted by SKB, along with Bristol Myers's Nuprin, quickly entered the market, leveraging ibuprofen's decade-long proven track record.